The significant enrichment of the early clonal driver GATA3 in the Nigerian group and a positive trend in its recurrence with African ancestry (proportion trend test, P = 0.0035) along with a significantly lower age at diagnosis in patients with tumors carrying GATA3 mutations is likely to be an underlying genomic event associated with young onset breast cancer. The gene discussed is GATA3; the disease is breast cancer.